Back
Enanta Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
ENTA
Enanta Pharmaceuticals
Last Price:
$5.65
Seasonality Move:
-4.74%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENTA is experiencing slight buying pressure.
Enanta Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.35 | Buy |
| 20-day SMA: | 5.09 | Buy |
| 50-day SMA: | 6.24 | Sell |
| 200-day SMA: | 9.22 | Sell |
| 8-day EMA: | 5.37 | Buy |
| 20-day EMA: | 4.86 | Buy |
| 50-day EMA: | 3.4 | Buy |
| 200-day EMA: | 1.21 | Buy |
Enanta Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 52.26 | Buy |
| Chaikin Money Flow: | 40436 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.74 - 5.82) | Buy |
| Bollinger Bands (100): | (4.93 - 7.41) | Sell |
Enanta Pharmaceuticals Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enanta Pharmaceuticals Stock
Is Enanta Pharmaceuticals Stock a Buy?
-
Enanta Pharmaceuticals share price is 5.58 while ENTA 8-day simple moving average is 5.35, which is a Buy signal.
-
The stock price of ENTA is 5.58 while Enanta Pharmaceuticals 20-day SMA is 5.09, which makes it a Buy.
-
Enanta Pharmaceuticals 50-day simple moving average is 6.24 while ENTA share price is 5.58, making it a Sell technically.
-
ENTA stock price is 5.58 and Enanta Pharmaceuticals 200-day simple moving average is 9.22, creating a Sell signal.
ENTA Technical Analysis vs Fundamental Analysis
Sell
29
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy or a Sell?
-
Enanta Pharmaceuticals stock is rated a SellThe current Enanta Pharmaceuticals [ENTA] share price is $5.58. The Score for ENTA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Enanta Pharmaceuticals Stock Info
Market Cap:
119M
Price in USD:
5.58
Share Volume:
179.1K
Enanta Pharmaceuticals 52-Week Range
52-Week High:
17.24
52-Week Low:
4.09
Sell
29
Enanta Pharmaceuticals (ENTA)
is a Sell
Enanta Pharmaceuticals Share Price Forecast
-
What is the Enanta Pharmaceuticals stock price today?The Enanta Pharmaceuticals stock price is 5.58 USD today.
-
Will ENTA stock go up or go down?Enanta Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Enanta Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enanta Pharmaceuticals is overvalued.
Is Enanta Pharmaceuticals Stock a Buy?
-
Enanta Pharmaceuticals share price is 5.58 while ENTA 8-day exponential moving average is 5.37, which is a Buy signal.
-
The stock price of ENTA is 5.58 while Enanta Pharmaceuticals 20-day EMA is 4.86, which makes it a Buy.
-
Enanta Pharmaceuticals 50-day exponential moving average is 3.40 while ENTA share price is 5.58, making it a Buy technically.
-
ENTA stock price is 5.58 and Enanta Pharmaceuticals 200-day simple moving average is 1.21, creating a Buy signal.
Fundamental Analysis of Enanta Pharmaceuticals
Is Enanta Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Enanta Pharmaceuticals
Should I short Enanta Pharmaceuticals stock?
-
ENTA Moving Average Covergence Divergence (MACD) indicator is 0.69, suggesting Enanta Pharmaceuticals is a Buy
-
Enanta Pharmaceuticals Relative Strength Index (RSI) is 52.26, which suggest Enanta Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Enanta Pharmaceuticals is (4.74 - 5.82), which suggest Enanta Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Enanta Pharmaceuticals is (4.93 - 7.41), which suggest Enanta Pharmaceuticals is a Sell
* Enanta Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.